Similar articles

• Is a placebo-controlled surgical trial an oxymoron?

  Boyle K, Batzer FR. Boyle K, et al. J Minim Invasive Gynecol. 2007 May-Jun;14(3):278-83. doi: 10.1016/j.jmig.2006.12.006. J Minim Invasive Gynecol. 2007. PMID: 17478356
• [Placebo and placebo-effects in the clinic and research].

  Schindel L. Schindel L. Arzneimittelforschung. 1967 Jul;17(7):892-917. Arzneimittelforschung. 1967. PMID: 4885152 Review. German. No abstract available.
• Paying for patient care in treatment research--who is responsible?

  Wittes RE. Wittes RE. Cancer Treat Rep. 1987 Feb;71(2):107-13. Cancer Treat Rep. 1987. PMID: 3100033 Clinical Trial. No abstract available.
• How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?

  Husereau D, Culyer AJ, Neumann P, Jacobs P. Husereau D, et al. Appl Health Econ Health Policy. 2015 Jun;13(3):273-9. doi: 10.1007/s40258-014-0133-6. Appl Health Econ Health Policy. 2015. PMID: 25316309
• Ethical framework for the use of sham procedures in clinical trials.

  Horng S, Miller FG. Horng S, et al. Crit Care Med. 2003 Mar;31(3 Suppl):S126-30. doi: 10.1097/01.CCM.0000054906.49187.67. Crit Care Med. 2003. PMID: 12626957 Review.